Analysen von Matthew Weston

18.11.25 Novo Nordisk Neutral UBS AG
11.11.25 Novo Nordisk Neutral UBS AG
10.11.25 Novo Nordisk Neutral UBS AG
06.11.25 Novo Nordisk Neutral UBS AG
05.11.25 Novo Nordisk Neutral UBS AG
04.11.25 Novartis Neutral UBS AG
30.10.25 GSK Neutral UBS AG
29.10.25 Novartis Neutral UBS AG
29.10.25 GSK Neutral UBS AG
24.10.25 GSK Neutral UBS AG
22.10.25 GSK Neutral UBS AG
22.10.25 Novo Nordisk Neutral UBS AG
13.10.25 Novo Nordisk Neutral UBS AG
13.10.25 Novartis Neutral UBS AG
10.10.25 Novartis Neutral UBS AG
10.10.25 Sartorius Stedim Biotech Neutral UBS AG
10.10.25 Sartorius vz. Neutral UBS AG
06.10.25 Novo Nordisk Neutral UBS AG
03.10.25 Novo Nordisk Neutral UBS AG
24.09.25 Novartis Neutral UBS AG
23.09.25 Novartis Neutral UBS AG
23.09.25 Novo Nordisk Neutral UBS AG
18.09.25 Novo Nordisk Neutral UBS AG
16.09.25 Novo Nordisk Neutral UBS AG
15.09.25 Novo Nordisk Neutral UBS AG
12.09.25 Novartis Neutral UBS AG
10.09.25 Novo Nordisk Neutral UBS AG
08.09.25 Novo Nordisk Neutral UBS AG
05.09.25 Novartis Neutral UBS AG
05.09.25 Novo Nordisk Neutral UBS AG
01.09.25 Novo Nordisk Neutral UBS AG
29.08.25 Novo Nordisk Neutral UBS AG
29.08.25 Novartis Neutral UBS AG
22.08.25 Novartis Neutral UBS AG
19.08.25 Novo Nordisk Neutral UBS AG
14.08.25 Bayer Neutral UBS AG
12.08.25 Novo Nordisk Neutral UBS AG
06.08.25 Bayer Neutral UBS AG
06.08.25 Novo Nordisk Neutral UBS AG
05.08.25 Novo Nordisk Neutral UBS AG
22.07.25 Sartorius vz. Neutral UBS AG
03.07.25 Novartis Neutral UBS AG
16.06.25 Novartis Neutral UBS AG
06.06.25 Sartorius Stedim Biotech Neutral UBS AG
29.04.25 Novartis Neutral UBS AG
17.04.25 Sartorius vz. Neutral UBS AG
16.04.25 Sartorius vz. Neutral UBS AG
10.04.25 Novartis Neutral UBS AG
09.04.25 Novartis Neutral UBS AG
13.02.25 Novartis Neutral UBS AG